JP2013043857A - External preparation composition - Google Patents
External preparation composition Download PDFInfo
- Publication number
- JP2013043857A JP2013043857A JP2011182495A JP2011182495A JP2013043857A JP 2013043857 A JP2013043857 A JP 2013043857A JP 2011182495 A JP2011182495 A JP 2011182495A JP 2011182495 A JP2011182495 A JP 2011182495A JP 2013043857 A JP2013043857 A JP 2013043857A
- Authority
- JP
- Japan
- Prior art keywords
- external preparation
- mass
- preparation composition
- hlb
- salicylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 51
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 70
- -1 polyoxyethylene Polymers 0.000 claims abstract description 48
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 35
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 35
- 150000005215 alkyl ethers Chemical class 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims abstract description 16
- 150000005846 sugar alcohols Polymers 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000002845 discoloration Methods 0.000 abstract description 16
- 238000000034 method Methods 0.000 description 10
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 8
- 206010000496 acne Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 2
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 2
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 2
- 229940043276 diisopropanolamine Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000012812 general test Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- ODFCWXVQZAQDSO-CMKODMSKSA-N (2s,4as,10ar)-1,1,4a-trimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-2,6-diol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)C1=C2C=C(C(C)C)C(O)=C1 ODFCWXVQZAQDSO-CMKODMSKSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- SJEYSFABYSGQBG-UHFFFAOYSA-M Patent blue Chemical compound [Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 SJEYSFABYSGQBG-UHFFFAOYSA-M 0.000 description 1
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000981 basic dye Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229950008138 carmellose Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229960005168 croscarmellose Drugs 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- OMRDZQXXMYCHBU-UHFFFAOYSA-N ethanol;propan-1-ol Chemical compound CCO.CCCO OMRDZQXXMYCHBU-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920001955 polyphenylene ether Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本発明は、サリチル酸を含有する外用剤組成物に関するものである。 The present invention relates to an external preparation composition containing salicylic acid.
サリチル酸は、角質剥離作用、面皰分解作用を有しており、落屑を促進することで、にきび治療効果を発揮するため、サリチル酸はにきび治療薬の有効成分として、ローション剤等に配合されている。しかしながら、サリチル酸は光や温度によって重合し、黄色の物質となるため、サリチル酸を配合した製剤は、経日の光暴露によって製剤が黄色に変色してくる問題があった。これを防ぐため、光を通さない容器に充填する等の施策がとられており、容器の自由度に制限があった。 Salicylic acid has an exfoliating action and a comedone-decomposing action, and exerts acne treatment effects by promoting desquamation, so salicylic acid is blended in lotions and the like as an active ingredient of an acne remedy. However, since salicylic acid is polymerized by light and temperature to form a yellow substance, a preparation containing salicylic acid has a problem that the preparation turns yellow when exposed to light over time. In order to prevent this, measures such as filling a container that does not transmit light have been taken, and the degree of freedom of the container has been limited.
本発明は上記事情に鑑みなされたもので、光暴露によるサリチル酸の変色を抑制し、変色が抑制された、サリチル酸を含有する外用剤組成物を提供することを目的とする。 This invention is made | formed in view of the said situation, and it aims at providing the external preparation composition containing a salicylic acid which suppressed discoloration of the salicylic acid by light exposure, and the discoloration was suppressed.
本発明者らは、上記目的を達成するため鋭意検討した結果、(A)サリチル酸、(B)エタノール及び/又はプロパノール、(C)HLBが15以上であるポリオキシエチレンアルキルエーテルをそれぞれ特定量で含有し、さらに、(B)/(A)で表される(A)成分と(B)成分の含有質量比を5以上とすることで、光暴露によるサリチル酸の変色を抑制し、サリチル酸を含有する製剤の変色を抑制できることを知見し、本発明をなすに至ったものである。 As a result of intensive studies to achieve the above object, the present inventors have determined that (A) salicylic acid, (B) ethanol and / or propanol, and (C) polyoxyethylene alkyl ether having HLB of 15 or more in specific amounts. In addition, the content ratio of the (A) component and the (B) component represented by (B) / (A) is set to 5 or more, thereby suppressing discoloration of salicylic acid due to light exposure and containing salicylic acid. It has been found that the discoloration of the preparation to be suppressed can be suppressed, and has led to the present invention.
従って、本発明は、下記外用剤組成物を提供する。
[1].(A)サリチル酸0.1〜5質量%、(B)エタノール及び/又はプロパノール3〜25質量%、(C)HLBが15以上であるポリオキシエチレンアルキルエーテル0.1〜5質量%、及び(D)水を含有し、(B)/(A)で表される(A)成分と(B)成分の含有質量比が5以上である外用剤組成物。
[2].透明容器に充填されてなる[1]記載の外用剤組成物。
[3].さらに、(E)多価アルコールを含有する[1]又は[2]記載の外用剤組成物。
[4].(A)サリチル酸を、(B)エタノール及び/又はプロパノールと(C)HLBが15以上であるポリオキシエチレンアルキルエーテルとに溶解した後、(D)水に添加する[1]又は[2]記載の外用剤組成物の製造方法。
[5].(A)サリチル酸を、(B)エタノール及び/又はプロパノールと(C)HLBが15以上であるポリオキシエチレンアルキルエーテルとに溶解した後、(E)多価アルコールを含有する(D)水に添加する[3]記載の外用剤組成物の製造方法。
Accordingly, the present invention provides the following external preparation composition.
[1]. (A) salicylic acid 0.1 to 5% by mass, (B) ethanol and / or propanol 3 to 25% by mass, (C) polyoxyethylene alkyl ether 0.1 to 5% by mass with HLB of 15 or more, and ( D) An external preparation composition containing water and having a mass ratio of the component (A) represented by (B) / (A) to the component (B) of 5 or more.
[2]. The external preparation composition according to [1], which is filled in a transparent container.
[3]. Furthermore, (E) The external preparation composition of [1] or [2] containing a polyhydric alcohol.
[4]. [1] or [2] description in which (A) salicylic acid is dissolved in (B) ethanol and / or propanol and (C) polyoxyethylene alkyl ether having HLB of 15 or more, and then (D) is added to water The manufacturing method of the external preparation composition.
[5]. (A) After salicylic acid is dissolved in (B) ethanol and / or propanol and (C) polyoxyethylene alkyl ether having HLB of 15 or more, (E) containing polyhydric alcohol (D) added to water The method for producing an external preparation composition according to [3].
本発明によれば、光暴露によるサリチル酸の変色を抑制し、変色が抑制された、サリチル酸を含有する外用剤組成物を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the external preparation composition containing a salicylic acid which suppressed discoloration of the salicylic acid by light exposure and the discoloration was suppressed can be provided.
以下、本発明について詳細に説明する。
本発明の外用剤組成物は、(A)サリチル酸0.1〜5質量%、(B)エタノール及び/又はプロパノール3〜25質量%、(C)HLBが15以上であるポリオキシエチレンアルキルエーテル0.1〜5質量%を含有し、(B)/(A)で表される(A)成分と(B)成分の含有質量比が5以上である。
Hereinafter, the present invention will be described in detail.
The external preparation composition of the present invention comprises (A) 0.1-5% by mass of salicylic acid, (B) 3-25% by mass of ethanol and / or propanol, and (C) polyoxyethylene alkyl ether 0 having an HLB of 15 or more. The content ratio of the component (A) and the component (B) represented by (B) / (A) is 5 or more.
(A)サリチル酸
サリチル酸は、角層剥離・溶解作用に加えて、殺菌作用、抗炎症作用等を有しており、二重盲験臨床試験においても、尋常性ざ瘡に対する治療効果が確認され、にきび治療薬の有効成分として広く用いられている。
(A) Salicylic acid Salicylic acid has a bactericidal action, an anti-inflammatory action, etc. in addition to the stratum corneum peeling / dissolving action, and in a double-blind clinical trial, the therapeutic effect against acne vulgaris has been confirmed Widely used as an active ingredient in acne treatments.
(B)エタノール及び/又はプロパノール
エタノール及びプロパノールは、サリチル酸の変色抑制剤として機能する。エタノール及びプロパノールとしては変性、未変性にかかわらず使用することができる。具体的には、甘糟化学産業(株)製の無水エタノール、三菱化学(株)製の一般アルコール95度合成無変性、信和アルコール(株)製の政府所定エタノール、片山化学工業(株)製及びBASFジャパン株式会社製のプロパノール等を挙げることができる。
(B) Ethanol and / or propanol Ethanol and propanol function as a discoloration inhibitor for salicylic acid. Ethanol and propanol can be used regardless of whether they are modified or unmodified. Specifically, absolute ethanol manufactured by Gansu Chemical Industry Co., Ltd., general alcohol 95-degree synthetic unmodified product manufactured by Mitsubishi Chemical Co., Ltd., government-specified ethanol manufactured by Shinwa Alcohol Co., Ltd., Katayama Chemical Industry Co., Ltd. Examples include propanol manufactured by BASF Japan Ltd.
本発明の変色抑制効果を得るためには、(A)サリチル酸、(B)エタノール及び/又はプロパノールの含有量、(B)/(A)で表される(A)成分と(B)成分の含有質量比が重要である。 In order to obtain the discoloration suppressing effect of the present invention, the contents of (A) salicylic acid, (B) ethanol and / or propanol, (B) / (A) represented by (A) component and (B) component The content mass ratio is important.
変色抑制効果の点から、(A)成分の含有量は、外用剤組成物全体に対して0.1〜5質量%であり、好ましくは0.2〜3質量%であり、より好ましくは0.5〜2質量%である。(B)成分の含有量は、外用剤組成物全体に対して3〜25質量%であり、好ましくは10〜25質量%であり、より好ましくは20〜25質量%である。なお、(B)成分は1種単独で又は2種以上を適宜組み合わせて用いることができ、2種以上用いる場合は、2種の合計量である。(B)成分の含有量が多すぎると、皮膚への刺激が強まり使用感が悪くなるため、上限は25質量%以下を選択することが望ましい。 From the viewpoint of the effect of suppressing discoloration, the content of the component (A) is 0.1 to 5% by mass, preferably 0.2 to 3% by mass, and more preferably 0 to the whole external preparation composition. 0.5 to 2% by mass. (B) Content of a component is 3-25 mass% with respect to the whole external preparation composition, Preferably it is 10-25 mass%, More preferably, it is 20-25 mass%. In addition, (B) component can be used individually by 1 type or in combination of 2 or more types, and when using 2 or more types, it is a total amount of 2 types. If the content of the component (B) is too large, irritation to the skin increases and the usability deteriorates, so it is desirable to select an upper limit of 25% by mass or less.
(B)/(A)で表される(A)成分と(B)成分の含有質量比は5以上であり、10以上が好ましく、40以上がより好ましい。5以上とすることで、目的とする変色抑制効果を得ることができる。また、上記比率が5未満であると、(A)サリチル酸の溶解性が低下し、結晶析出の問題が生じる。なお、上限は特に限定されないが、250を選択できる。 The mass ratio of the component (A) and the component (B) represented by (B) / (A) is 5 or more, preferably 10 or more, and more preferably 40 or more. By setting it to 5 or more, the intended discoloration suppressing effect can be obtained. On the other hand, when the ratio is less than 5, the solubility of (A) salicylic acid is lowered, causing a problem of crystal precipitation. The upper limit is not particularly limited, but 250 can be selected.
(C)HLBが15以上であるポリオキシエチレンアルキルエーテル
ポリオキシエチレンアルキルエーテルは、サリチル酸の変色抑制剤として機能する。ポリオキシエチレンアルキルエーテルは、そのHLB値が15以上であることが必要であり、好ましくは17〜20のポリオキシエチレンアルキルエーテルである。HLB値が低すぎるポリオキシエチレンアルキルエーテルだと、(A)サリチル酸を十分に可溶化することができない。ポリオキシエチレンアルキルエーテルのアルキル基の炭素数は12〜22が好ましい。HLBの上限は特に限定されないが、20を選択できる。
(C) Polyoxyethylene alkyl ether with HLB of 15 or more Polyoxyethylene alkyl ether functions as a discoloration inhibitor for salicylic acid. The polyoxyethylene alkyl ether needs to have an HLB value of 15 or more, and is preferably a polyoxyethylene alkyl ether having 17 to 20. If the polyoxyethylene alkyl ether has an HLB value that is too low, (A) salicylic acid cannot be sufficiently solubilized. As for carbon number of the alkyl group of polyoxyethylene alkyl ether, 12-22 are preferable. Although the upper limit of HLB is not specifically limited, 20 can be selected.
HLBが15以上であるポリオキシエチレンアルキルエーテルの例としては、具体的には、例えば、ポリオキシエチレン(15)セチルエーテル(HLB=15.5)、ポリオキシエチレン(20)ベヘニルエーテル(HLB=16.5)、ポリオキシエチレン(23)セチルエーテル(HLB=18)、ポリオキシエチレン(25)セチルエーテル(HLB=18.5)、ポリオキシエチレン(30)セチルエーテル(HLB=19.5)、ポリオキシエチレン(20)オレイルエーテル(HLB=17)、ポリオキシエチレン(30)ベヘニルエーテル(HLB=18)、ポリオキシエチレン(20)ステアリルエーテル(HLB=18)、ポリオキシエチレン(21)ラウリルエーテル(HLB=19)、ポリオキシエチレン(25)ラウリルエーテル(HLB=19.5)等を挙げることができる。中でも、ポリオキシエチレン(15)セチルエーテル(HLB=15.5)、ポリオキシエチレン(20)ベヘニルエーテル(HLB=16.5)、ポリオキシエチレン(20)オレイルエーテル(HLB=17)、ポリオキシエチレン(30)ベヘニルエーテル(HLB=18)、ポリオキシエチレン(23)セチルエーテル(HLB=18)、ポリオキシエチレン(25)セチルエーテル(HLB=18.5)、ポリオキシエチレン(30)セチルエーテル(HLB=19.5)、ポリオキシエチレン(20)ステアリルエーテル(HLB=18)、ポリオキシエチレン(21)ラウリルエーテル(HLB=19)、ポリオキシエチレン(25)ラウリルエーテル(HLB=19.5)等がより効果的である。これらのポリオキシエチレンアルキルエーテルは1種単独で又は2種以上を適宜組み合わせて使用することができる。なお、単独ではHLB値が15未満のポリオキシエチレンアルキルエーテルであっても、上記例示の界面活性剤を併用して、界面活性剤全体としてのHLB値が15以上となるように調整して使用することができる。 Specific examples of the polyoxyethylene alkyl ether having an HLB of 15 or more include, for example, polyoxyethylene (15) cetyl ether (HLB = 15.5), polyoxyethylene (20) behenyl ether (HLB = 16.5), polyoxyethylene (23) cetyl ether (HLB = 18), polyoxyethylene (25) cetyl ether (HLB = 18.5), polyoxyethylene (30) cetyl ether (HLB = 19.5) , Polyoxyethylene (20) oleyl ether (HLB = 17), polyoxyethylene (30) behenyl ether (HLB = 18), polyoxyethylene (20) stearyl ether (HLB = 18), polyoxyethylene (21) lauryl Ether (HLB = 19), polyoxyethylene (25) And the like can be mentioned selling ether (HLB = 19.5). Among them, polyoxyethylene (15) cetyl ether (HLB = 15.5), polyoxyethylene (20) behenyl ether (HLB = 16.5), polyoxyethylene (20) oleyl ether (HLB = 17), polyoxy Ethylene (30) behenyl ether (HLB = 18), polyoxyethylene (23) cetyl ether (HLB = 18), polyoxyethylene (25) cetyl ether (HLB = 18.5), polyoxyethylene (30) cetyl ether (HLB = 19.5), polyoxyethylene (20) stearyl ether (HLB = 18), polyoxyethylene (21) lauryl ether (HLB = 19), polyoxyethylene (25) lauryl ether (HLB = 19.5) ) Etc. are more effective. These polyoxyethylene alkyl ethers can be used singly or in appropriate combination of two or more. Even if it is a polyoxyethylene alkyl ether having an HLB value of less than 15 alone, it is used by adjusting the HLB value of the surfactant as a whole to 15 or more in combination with the surfactants exemplified above. can do.
なお、「HLB」は、親水性−親油性バランス(Hydrophile−Lipophile Balance)、つまり、界面活性剤の分子が有する親水性と親油性との相対的な強さのことを意味し、その親水親油バランスを数量的に表したものをいう。具体的には、Griffinの方法により求められた値である(吉田、進藤、大垣、山中共編、「新版界面活性剤ハンドブック」,工学図書株式会社,1991年,第234頁参照)。 “HLB” means a hydrophilic-lipophilic balance, that is, a relative strength between hydrophilicity and lipophilicity of a molecule of a surfactant. This is a quantitative representation of the oil balance. Specifically, it is a value determined by the Griffin method (see Yoshida, Shindo, Ogaki, Yamanaka, edited by “New Edition Surfactant Handbook”, Engineering Books Co., Ltd., 1991, page 234).
(C)成分の含有量は、外用剤組成物全体に対して0.1〜5質量%であり、0.5〜5質量%が好ましく、1.5〜5質量%がより好ましい。なお、(C)成分の含有量が5質量%を超えると、製造時に泡が発生し製造性が悪くなることから、上限を5質量%以下とする。 (C) Content of a component is 0.1-5 mass% with respect to the whole external preparation composition, 0.5-5 mass% is preferable, and 1.5-5 mass% is more preferable. In addition, when content of (C) component exceeds 5 mass%, a bubble will generate | occur | produce at the time of manufacture and manufacturability will worsen, Therefore An upper limit shall be 5 mass% or less.
(D)水
水は特に限定されず、精製水、蒸留水、イオン交換水、上水等を適宜用いることができる。この場合、水はバランスとして配合し、他の成分量により調整するが、例えば、10〜97質量%が好ましい。
(D) Water Water is not particularly limited, and purified water, distilled water, ion exchange water, clean water, and the like can be used as appropriate. In this case, water is blended as a balance and adjusted by the amount of other components, but is preferably 10 to 97% by mass, for example.
本発明の外用剤組成物には、サリチル酸の変色抑制、外用剤組成物の低温安定性向上の点から、(E)多価アルコールを配合することが好ましい。多価アルコールは、一分子中に水酸基を2個以上有するアルコールで、具体的には、グリセリン、1,3−ブチレングリコール、エチレングリコール、ポリプロピレングリコール、ポリエチレングリコール(マクロゴール400)等が挙げられる。これらは1種単独で又は2種以上を適宜組み合わせて用いることができる。多価アルコールの含有量は、外用剤組成物全体に対して10〜50質量%が好ましく、20〜30質量%がより好ましい。含有量が10質量%未満になると、低温における結晶析出のおそれがあり、50質量%を超えるとべたつきが生じ、使用感が悪くなるおそれがある。 It is preferable to mix | blend (E) polyhydric alcohol with the external preparation composition of this invention from the point of the discoloration suppression of a salicylic acid and the low temperature stability improvement of an external preparation composition. The polyhydric alcohol is an alcohol having two or more hydroxyl groups in one molecule, and specifically includes glycerin, 1,3-butylene glycol, ethylene glycol, polypropylene glycol, polyethylene glycol (Macrogol 400) and the like. These can be used individually by 1 type or in combination of 2 or more types. 10-50 mass% is preferable with respect to the whole external preparation composition, and, as for content of a polyhydric alcohol, 20-30 mass% is more preferable. If the content is less than 10% by mass, there is a risk of crystal precipitation at a low temperature, and if it exceeds 50% by mass, stickiness may occur and the usability may deteriorate.
本発明の外用剤組成物は、上記(A)〜(E)成分の他に、本発明の効果を損なわない範囲で、任意成分を配合することができる。任意成分としては、高分子化合物、pH調整剤、キレート剤、防腐剤、香料、色素等が挙げられ、1種単独で又は2種以上を適宜組み合わせて適量用いることができる。 The external preparation composition of this invention can mix | blend arbitrary components in the range which does not impair the effect of this invention other than said (A)-(E) component. Examples of the optional component include a polymer compound, a pH adjuster, a chelating agent, an antiseptic, a fragrance, a dye, and the like, which can be used alone or in appropriate combination of two or more.
高分子化合物としては、水又は低級アルコール/水の混合溶媒系に可溶な高分子化合物が好ましく、例えばヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース、カルメロース、クロスカルメロース、メチルセルロース等のセルロース誘導体、部分α化澱粉等の加工澱粉、ポリビニルアルコール、ポリビニルピロリドン、クロスポビドン、ポリエチレングリコール、キサンタンガム、カラギーナン、アルギン酸ナトリウム、アラビアゴム、グアーガム、ローカストビーンガム、プルラン、ゼラチン、カルボキシビニルポリマー、アクリル酸・メタクリル酸アルキル共重合体、ポリアクリル酸ナトリウム等が挙げられる。高分子化合物の含有量は、にきび用外用剤組成物の設定粘度により適宜選定されるが、外用剤組成物全体に対して0.01〜10質量%が好ましく、より好ましくは0.05〜5質量%である。 The polymer compound is preferably a polymer compound that is soluble in water or a mixed solvent system of lower alcohol / water, such as cellulose derivatives such as hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, carmellose, croscarmellose, methylcellulose, Processed starch such as partially pregelatinized starch, polyvinyl alcohol, polyvinylpyrrolidone, crospovidone, polyethylene glycol, xanthan gum, carrageenan, sodium alginate, gum arabic, guar gum, locust bean gum, pullulan, gelatin, carboxyvinyl polymer, acrylic acid / methacrylic acid Examples thereof include alkyl copolymers and sodium polyacrylate. Although content of a high molecular compound is suitably selected by the setting viscosity of the external preparation composition for acne, 0.01-10 mass% is preferable with respect to the whole external preparation composition, More preferably, it is 0.05-5. % By mass.
pH調整剤としては、塩酸、リン酸、ホウ酸等の無機酸、乳酸、酒石酸、クエン酸等の有機酸、水酸化ナトリウム、水酸化カリウム、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、ジイソプロパノールアミン、トリイソプロパノールアミン、トロメタミン等の各種アミン類、リン酸水素カリウム、リン酸水素ナトリウム等のリン酸塩、クエン酸ナトリウム、乳酸ナトリウム等の有機塩類等が挙げられる。ジイソプロパノールアミン、トリイソプロパノールアミン及びトリエタノールアミンは、特に酸性薬物を使用した場合のpH安定性が良好であるため、好ましい。pH調整剤の含有量は、設定pHにより適宜選択することができる。 pH adjusters include inorganic acids such as hydrochloric acid, phosphoric acid and boric acid, organic acids such as lactic acid, tartaric acid and citric acid, sodium hydroxide, potassium hydroxide, monoethanolamine, diethanolamine, triethanolamine, diisopropanolamine And various amines such as triisopropanolamine and tromethamine, phosphates such as potassium hydrogenphosphate and sodium hydrogenphosphate, and organic salts such as sodium citrate and sodium lactate. Diisopropanolamine, triisopropanolamine, and triethanolamine are preferred because pH stability is particularly good when an acidic drug is used. The content of the pH adjusting agent can be appropriately selected depending on the set pH.
キレート剤としては、ピロリン酸塩、ヘキサメタリン酸塩、グルコン酸塩、エデト酸塩等が挙げられる。キレート剤を配合する場合、キレート剤の含有量は、外用剤組成物全体に対して0.001〜5質量%が好ましく、より好ましくは0.01〜5質量%である。 Examples of the chelating agent include pyrophosphate, hexametaphosphate, gluconate, edetate and the like. When mix | blending a chelating agent, 0.001-5 mass% is preferable with respect to the whole external preparation composition, More preferably, content of a chelating agent is 0.01-5 mass%.
防腐剤としては、ジブチルヒドロキシトルエン、安息香酸類、パラベン類、塩化ベンザルコニウム、塩化ベンゼトニウム、ソルビン酸及びその塩類、ホウ酸、ホウ砂等が挙げられる。ジブチルヒドロキシトルエン、クエン酸及びその塩が好ましい。防腐剤を配合する場合、防腐剤の含有量は、外用剤組成物全体に対して0.005〜5質量%が好ましく、より好ましくは0.01〜1質量%である。 Examples of the preservative include dibutylhydroxytoluene, benzoic acids, parabens, benzalkonium chloride, benzethonium chloride, sorbic acid and its salts, boric acid, borax and the like. Dibutylhydroxytoluene, citric acid and its salts are preferred. When mix | blending antiseptic | preservative, 0.005-5 mass% is preferable with respect to the whole external preparation composition, More preferably, content of antiseptic | preservative is 0.01-1 mass%.
色素は、酸性染料、塩基性染料、酸化染料、顔料等の外用剤(化粧品、医薬品)に使用可能な色素を、任意に使用可能である。香料は、天然香料や合成香料を、特に制限なく使用することができる。例えば、天然香料としては、ペパーミント油、スペアミント油、ジャスミン油、レモン油、オレンジ油、ライム油、マンダリン油、ローズ油、ローズマリー油等の植物性香料が挙げられる。合成香料としてはモノテルペン類、ジテルペン類、セスキテルペン類等、具体的にはゲラニオール、リナロール、シトロネロール、ネロール、リモネン、ピネン、カンフェン、シトラール、シトロネラール、シネオール、クルクメン、ヒノキ酸、ヒノキオール、フィトール等が挙げられる。色素及び香料を配合する場合、色素及び香料のそれぞれの含有量は、外用剤組成物全体に対して0.0001〜5質量%が好ましく、より好ましくは0.0001〜1質量%である。 As the pigment, any pigment that can be used for external preparations (cosmetics, pharmaceuticals) such as acid dyes, basic dyes, oxidation dyes, and pigments can be arbitrarily used. As the fragrance, a natural fragrance or a synthetic fragrance can be used without any particular limitation. Examples of natural flavors include vegetable flavors such as peppermint oil, spearmint oil, jasmine oil, lemon oil, orange oil, lime oil, mandarin oil, rose oil, rosemary oil and the like. Synthetic fragrances include monoterpenes, diterpenes, sesquiterpenes, etc., specifically geraniol, linalool, citronellol, nerol, limonene, pinene, camphene, citral, citronellal, cineole, curcumene, hinokic acid, hinokiol, phytol, etc. Is mentioned. When mix | blending a pigment | dye and a fragrance | flavor, 0.0001-5 mass% is preferable with respect to the whole external preparation composition, and, as for each content of a pigment | dye and a fragrance | flavor, More preferably, it is 0.0001-1 mass%.
本発明の外用剤組成物の剤型としては特に限定されないが、液剤が好ましい。本発明の外用剤組成物の粘度は、0.5〜50,000mPa・sが好ましく、より好ましくは0.5〜1,000mPa・sであり、さらに好ましくは0.5〜500mPa・sである。粘度が低すぎると液が垂れる等の使用性が悪くなる場合があり、高すぎるとボトルから液が出難くなったり、患部に伸ばし難くなったりする場合がある。なお、本発明において、粘度は、日本薬局方一般試験法粘度測定法、第2法回転粘度計法に従って測定した25℃における値である。 Although it does not specifically limit as a dosage form of the external preparation composition of this invention, A liquid agent is preferable. As for the viscosity of the external preparation composition of this invention, 0.5-50,000 mPa * s is preferable, More preferably, it is 0.5-1,000 mPa * s, More preferably, it is 0.5-500 mPa * s. . If the viscosity is too low, the usability such as dripping of the liquid may be deteriorated, and if it is too high, the liquid may not be easily discharged from the bottle or may not be easily extended to the affected area. In addition, in this invention, a viscosity is a value in 25 degreeC measured according to the Japanese Pharmacopoeia general test method viscosity measuring method and the 2nd method rotational viscometer method.
本発明の外用剤組成物のpHは、角層剥離、溶解作用及び皮膚刺激性の観点から、2〜5がより好ましく、3〜4がより好ましい。pH2より酸性領域とすると皮膚刺激を起こす場合があり、この範囲とすることでサリチル酸の効果がより発揮される。なお、本発明において、pHは、日本薬局方一般試験法、pH測定法により測定した値である。 The pH of the external preparation composition of the present invention is more preferably 2 to 5 and more preferably 3 to 4 from the viewpoints of stratum corneum peeling, dissolution action and skin irritation. If it is in the acidic range from pH 2, skin irritation may occur, and the effect of salicylic acid is more exerted by setting this range. In addition, in this invention, pH is the value measured by the Japanese Pharmacopoeia general test method and the pH measurement method.
本発明の外用剤組成物はサリチル酸が含まれているため、にきび治療・予防用、角質ケア剤、白癬治療薬、殺菌剤として好適である。 Since the external preparation composition of the present invention contains salicylic acid, it is suitable for acne treatment / prevention, keratin care agent, tinea remedy, and bactericidal agent.
本発明の外用剤組成物は、サリチル酸に起因する組成物の変色抑制効果を有するため、容器は特に限定されず、透明容器を含む任意の容器に充填できる。本発明では透明容器を以下のように定義する。透明容器とは、照度約300ルクスの下で実施した際、256階調のグレースケールにおいて220階調の濃さで描いた外形7.0mm、内径5.5mmの「○」印を、容器を通して視認できる透過性を有することとする。 Since the external preparation composition of the present invention has the effect of suppressing discoloration of the composition resulting from salicylic acid, the container is not particularly limited and can be filled into any container including a transparent container. In the present invention, the transparent container is defined as follows. A transparent container means that when implemented under an illuminance of about 300 lux, a “○” mark with an outer diameter of 7.0 mm and an inner diameter of 5.5 mm drawn on a gray scale of 256 gradations with a density of 220 gradations is passed through the container. It shall have transparency which can be visually recognized.
容器の素材は、ガラスや樹脂等を使用することができる。樹脂は具体的には、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ポリエチレンナフタレート、ポリアリレート、ポリスチレン、アクリロニトリルブタジエンスチレン、ポリエステル、ポリフェニレンエーテル、ポリカーボネート、ポリスルホン、ポリアミド、硬質塩化ビニル、ポリイミド、セルロースアセテート及びそれらの共重合体や混合物等が挙げられる。紫外線吸収剤や色素を含有又はコーティングされたものだけでなく、透明な容器に充填することも可能である。本発明は、透明容器に充填されてなる外用剤組成物とすることもでき、外用剤組成物とこれを充填した透明容器とからなる外用剤製品とすることもできる。 Glass, resin, or the like can be used as the material of the container. Specific examples of the resin include polyethylene, polypropylene, polyethylene terephthalate, polyethylene naphthalate, polyarylate, polystyrene, acrylonitrile butadiene styrene, polyester, polyphenylene ether, polycarbonate, polysulfone, polyamide, hard vinyl chloride, polyimide, cellulose acetate, and co-polymers thereof. A polymer, a mixture, etc. are mentioned. In addition to those containing or coated with ultraviolet absorbers and pigments, it is possible to fill transparent containers. This invention can also be set as the external preparation composition with which a transparent container is filled, and can also be set as the external preparation product which consists of an external preparation composition and the transparent container filled with this.
本発明の外用剤組成物の製造方法は特に限定されないが、例えば、(A)サリチル酸を、(B)エタノール及び/又はプロパノールと(C)HLBが15以上であるポリオキシエチレンアルキルエーテルとに溶解した後、(D)水に添加する方法が挙げられる。(D)にはその他成分を配合してもよく、例えば、上記多価アルコールを溶解させた水溶液とすることもできる。上記(A)成分を、(B)成分及び(C)成分に溶解する順序は特に限定されず、(A)成分を(B)成分に溶解した液に、加温して融解した(C)成分を加えてもよい。なお、得られた液を、孔径0.45〜100μmのフィルターでろ過することが望ましい。 Although the manufacturing method of the external preparation composition of this invention is not specifically limited, For example, (A) salicylic acid is melt | dissolved in (B) ethanol and / or propanol and (C) polyoxyethylene alkyl ether whose HLB is 15 or more. (D) The method of adding to water is mentioned. In (D), other components may be blended, and for example, an aqueous solution in which the polyhydric alcohol is dissolved may be used. The order in which the component (A) is dissolved in the component (B) and the component (C) is not particularly limited. The solution (A) is dissolved in the component (B) and heated to melt (C). Ingredients may be added. In addition, it is desirable to filter the obtained liquid with a filter having a pore diameter of 0.45 to 100 μm.
また、本発明は、(A)サリチル酸0.1〜5質量%及び(D)水を含有する外用剤組成物に、(B)エタノール及び/又はプロパノール3〜25質量%、(C)HLBが15以上であるポリオキシエチレンアルキルエーテル0.1〜5質量%を配合すると共に、(B)/(A)で表される(A)成分と(B)成分の含有質量比が5以上となるように配合することを特徴とする、上記(A)サリチル酸を含有する外用剤組成物の変色抑制方法を提供する。なお好ましい成分、量等は上記と同様である。 Moreover, this invention is (A) 0.1-5 mass% of salicylic acid, and (D) the external preparation composition containing water, (B) ethanol and / or 3-25 mass% of propanol, (C) HLB contains. While blending 0.1-5 mass% of polyoxyethylene alkyl ether which is 15 or more, the content mass ratio of (A) component and (B) component represented by (B) / (A) is 5 or more. The above-described (A) salicylic acid-containing external preparation composition containing the above-described (A) is provided with a method for suppressing discoloration. Preferred components, amounts, etc. are the same as above.
以下、実施例及び比較例を示し、本発明を具体的に説明するが、本発明は下記の実施例に制限されるものではない。なお、下記の例において特に明記のない場合は、組成の「%」は質量%、比率は質量比を示し、表中の各成分の量は純分換算した量である。 EXAMPLES Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated concretely, this invention is not restrict | limited to the following Example. In the following examples, unless otherwise specified, “%” in the composition indicates mass%, the ratio indicates the mass ratio, and the amount of each component in the table is an amount converted into a pure component.
[実施例1〜23、比較例1〜7]
表1〜5に示す組成の外用剤組成物(ローション剤)を下記方法で調製した。得られた外用剤組成物について下記評価を行った。結果を表中に併記する。
<調製方法>
(A)サリチル酸を、(B)エタノール及び/又はプロパノールに溶解し、加温して融解した(C)ポリオキシエチレンアルキルエーテルを加えて溶かし、この液を、多価アルコールを混合した(D)精製水に添加し十分に攪拌して、外用剤組成物(ローション剤)を得た。
[Examples 1 to 23, Comparative Examples 1 to 7]
External preparation compositions (lotion agents) having the compositions shown in Tables 1 to 5 were prepared by the following method. The following evaluation was performed about the obtained external preparation composition. The results are also shown in the table.
<Preparation method>
(A) Salicylic acid was dissolved in (B) ethanol and / or propanol, heated and melted (C) polyoxyethylene alkyl ether was added and dissolved, and this liquid was mixed with polyhydric alcohol (D) The mixture was added to purified water and stirred sufficiently to obtain an external preparation composition (lotion agent).
<製剤の色調の測定>
外用剤組成物(ローション剤)を無色透明のガラス容器に充填し、直射日光のあたる場所に静置した(照射量:3.5MJ/m2)。その後、色差計(日本電色工業株式会社製、SE200)にて、照射前後の外用剤組成物(ローション剤)のb*値を測定し、下記Δb*値を得た。
Δb*値=日光照射後の外用剤組成物b*値−日光照射前のb*値
得られたΔb*値の結果から、Δb*値から、色調変化の抑制を下記判定基準で示す。◎〜△の範囲を許容範囲とする。
[判定基準]
◎:Δb*値が0.35未満
○:Δb*値が0.35以上〜0.6未満
△:Δb*値が0.6以上〜1.0未満
×:Δb*値が1.0以上
<Measurement of formulation color tone>
The external preparation composition (lotion agent) was filled in a colorless and transparent glass container and allowed to stand in a place exposed to direct sunlight (irradiation amount: 3.5 MJ / m 2 ). Then, b * value of the external preparation composition (lotion agent) before and after irradiation was measured with a color difference meter (Nippon Denshoku Industries Co., Ltd. SE200), and the following Δb * value was obtained.
Δb * value = external preparation composition after irradiation with sunlight b * value−b * value before irradiation with sunlight From the result of the obtained Δb * value, suppression of color tone change is shown by the following criteria. The range of 〜 to △ is the allowable range.
[Criteria]
◎: Δb * value is less than 0.35 ○: Δb * value is 0.35 or more and less than 0.6 Δ: Δb * value is 0.6 or more and less than 1.0 x: Δb * value is 1.0 or more
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011182495A JP5929040B2 (en) | 2011-08-24 | 2011-08-24 | External preparation composition and method for suppressing discoloration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011182495A JP5929040B2 (en) | 2011-08-24 | 2011-08-24 | External preparation composition and method for suppressing discoloration |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013043857A true JP2013043857A (en) | 2013-03-04 |
JP5929040B2 JP5929040B2 (en) | 2016-06-01 |
Family
ID=48008028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011182495A Active JP5929040B2 (en) | 2011-08-24 | 2011-08-24 | External preparation composition and method for suppressing discoloration |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5929040B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2024014991A (en) * | 2016-11-25 | 2024-02-01 | ロート製薬株式会社 | Acne prevention and/or treatment for the back |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5551017A (en) * | 1978-10-12 | 1980-04-14 | Lion Corp | Acetylsalicylic acid solid preparation |
JPH09216820A (en) * | 1996-02-09 | 1997-08-19 | Lion Corp | Skin ointment preparation |
JP2000053529A (en) * | 1998-06-05 | 2000-02-22 | Shiseido Co Ltd | Agent for external use for skin |
JP2002212105A (en) * | 2001-01-22 | 2002-07-31 | Lion Corp | Aqueous skin care composition |
JP2003012532A (en) * | 2001-07-06 | 2003-01-15 | Maruzen Pharmaceut Co Ltd | Hyaluronidase inhibitor, hexosaminidase liberation inhibitor, cyclic amp phosphodiesterase inhibitor and cosmetic for ameliorating skin roughening |
WO2005027932A1 (en) * | 2003-09-22 | 2005-03-31 | Nisshin Kyorin Pharmaceutical Co., Ltd. | 5-aminosalicylic acid solid preparation improved in discoloration and method of storing the same |
JP2006348035A (en) * | 2006-07-06 | 2006-12-28 | Kose Corp | Preparation suitable for external application |
JP2008110993A (en) * | 2008-01-29 | 2008-05-15 | Mandom Corp | Antibacterial composition and skin care preparation |
-
2011
- 2011-08-24 JP JP2011182495A patent/JP5929040B2/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5551017A (en) * | 1978-10-12 | 1980-04-14 | Lion Corp | Acetylsalicylic acid solid preparation |
JPH09216820A (en) * | 1996-02-09 | 1997-08-19 | Lion Corp | Skin ointment preparation |
JP2000053529A (en) * | 1998-06-05 | 2000-02-22 | Shiseido Co Ltd | Agent for external use for skin |
JP2002212105A (en) * | 2001-01-22 | 2002-07-31 | Lion Corp | Aqueous skin care composition |
JP2003012532A (en) * | 2001-07-06 | 2003-01-15 | Maruzen Pharmaceut Co Ltd | Hyaluronidase inhibitor, hexosaminidase liberation inhibitor, cyclic amp phosphodiesterase inhibitor and cosmetic for ameliorating skin roughening |
WO2005027932A1 (en) * | 2003-09-22 | 2005-03-31 | Nisshin Kyorin Pharmaceutical Co., Ltd. | 5-aminosalicylic acid solid preparation improved in discoloration and method of storing the same |
JP2006348035A (en) * | 2006-07-06 | 2006-12-28 | Kose Corp | Preparation suitable for external application |
JP2008110993A (en) * | 2008-01-29 | 2008-05-15 | Mandom Corp | Antibacterial composition and skin care preparation |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2024014991A (en) * | 2016-11-25 | 2024-02-01 | ロート製薬株式会社 | Acne prevention and/or treatment for the back |
Also Published As
Publication number | Publication date |
---|---|
JP5929040B2 (en) | 2016-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5556339B2 (en) | Acne preparation for external use | |
JP5989095B2 (en) | Transdermal composition of ibuprofen and method of use thereof | |
JP2018021002A (en) | Pharmaceutical preparation containing loxoprofen | |
JP6189668B2 (en) | Loxoprofen-containing external coating | |
JP2017226705A (en) | Loxoprofen-containing solid preparation for external use | |
TW201406376A (en) | Composition for agent for external use | |
JP2021035966A (en) | Pharmaceutical preparation | |
JP6344947B2 (en) | Loxoprofen-containing solid preparation for external use | |
JP2015218147A (en) | Liranaftate-containing external pharmaceutical composition | |
TWI285115B (en) | Fill liquid composition for ibuprofen capsule and capsule preparation | |
JP6420102B2 (en) | Loxoprofen-containing external solid preparation and storage stabilizer for the external solid preparation | |
WO2023277075A1 (en) | Topical skin agent containing heparinoid and loxoprofen or salt thereof | |
JP5929040B2 (en) | External preparation composition and method for suppressing discoloration | |
JP2020011903A (en) | External composition | |
JP6114646B2 (en) | Loxoprofen-containing solid preparation for external use | |
JP6420101B2 (en) | External application agent containing loxoprofen | |
JP6503626B2 (en) | Pharmaceutical composition | |
JP6503627B2 (en) | Pharmaceutical liquid composition | |
WO2017183714A1 (en) | Ophthalmic composition | |
JP2018039775A (en) | Loxoprofen-containing pharmaceutical preparation | |
JP7550014B2 (en) | Pharmaceutical Compositions | |
JP2003095983A (en) | Skin care preparation composition | |
JP7558545B1 (en) | Loxoprofen-containing topical skin preparation | |
KR20200112919A (en) | Emulsified gel composition containing diclofenac | |
JP7590833B2 (en) | Composition for topical application to the skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140617 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150626 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150630 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150828 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160126 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160224 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160405 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160418 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5929040 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |